1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
EVOLUTION OF A beta 42 AND A beta 40 LEVELS AND A beta 42/A beta 40 RATIO IN PLASMA DURING PROGRESSION OF ALZHEIMER'S DISEASE: A MULTICENTER ASSESSMENT
Blennow, K. ; De Meyer, G. ; Hansson, Oskar LU
; Minthon, Lennart
LU
; Wallin, A.
; Zetterberg, H.
; Lewczuk, P.
; Vanderstichele, H.
; Vanmechelen, E.
and Kornhuber, J.
, et al.
(2009)
1st Cconference Clinical Trials on Alzheimers Disease (CTAD)
13(3).
p.205-208
Mark
- 2001
- Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice
- Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders
- Both total and phosphorylated tau are increased in Alzheimer's disease
- Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values
- 2000
- CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
- Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma
- 1999
- Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
- Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample